0001104659-23-095014.txt : 20230824 0001104659-23-095014.hdr.sgml : 20230824 20230824214700 ACCESSION NUMBER: 0001104659-23-095014 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230823 FILED AS OF DATE: 20230824 DATE AS OF CHANGE: 20230824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIZZARI JEAN-PIERRE CENTRAL INDEX KEY: 0001630914 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39069 FILM NUMBER: 231203693 MAIL ADDRESS: STREET 1: 235 LAUREL LN CITY: HAVERFOLD STATE: PA ZIP: 19041 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aprea Therapeutics, Inc. CENTRAL INDEX KEY: 0001781983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 BUSINESS PHONE: 267-370-5219 MAIL ADDRESS: STREET 1: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 4 1 tm2324788-3_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2023-08-23 0 0001781983 Aprea Therapeutics, Inc. APRE 0001630914 BIZZARI JEAN-PIERRE 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 1 0 0 0 0 Stock Options (Right to Buy) 3.65 2023-08-23 4 A 0 12500 0.00 A 2033-08-23 Common Stock 12500 12500 D These options shall vest in full on the two year anniversary of the grant date, subject to the reporting person's continued service on the Issuer's board of Directors through and including the applicable vesting date. /s/ John Hamill, as Attorney-in-Fact 2023-08-24